Found: 15
Select item for more details and to access through your institution.
A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 755, doi. 10.1007/s00280-021-04340-z
- By:
- Publication type:
- Article
The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 771, doi. 10.1007/s00280-021-04337-8
- By:
- Publication type:
- Article
Antitumor efficacy of CHMFL-KIT-110 solid dispersion in mouse xenograft models of human gastrointestinal stromal tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 825, doi. 10.1007/s00280-021-04329-8
- By:
- Publication type:
- Article
Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 837, doi. 10.1007/s00280-021-04327-w
- By:
- Publication type:
- Article
Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 845, doi. 10.1007/s00280-021-04339-6
- By:
- Publication type:
- Article
Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 857, doi. 10.1007/s00280-021-04341-y
- By:
- Publication type:
- Article
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 867, doi. 10.1007/s00280-021-04326-x
- By:
- Publication type:
- Article
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 879, doi. 10.1007/s00280-021-04334-x
- By:
- Publication type:
- Article
A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 887, doi. 10.1007/s00280-021-04338-7
- By:
- Publication type:
- Article
Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 899, doi. 10.1007/s00280-021-04333-y
- By:
- Publication type:
- Article
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 911, doi. 10.1007/s00280-021-04316-z
- By:
- Publication type:
- Article
Comment on "Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase".
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 919, doi. 10.1007/s00280-021-04345-8
- By:
- Publication type:
- Article